It is more likely that the national healthcare systems eat up a large portion of the cost difference. It is not clear from the dataset however if this is purchase cost or end-user cost.
Prescription medication in Australia for example is heavily subsidised.
Finland isn’t on that list, but the purchase cost here before any socialized healthcare rebates is ~110€ for a month’s dose of Ozempic, which is in line with the other European countries, so presumably all the prices there are before any rebates.
It is more likely that the national healthcare systems eat up a large portion of the cost difference. It is not clear from the dataset however if this is purchase cost or end-user cost.
Prescription medication in Australia for example is heavily subsidised.
Finland isn’t on that list, but the purchase cost here before any socialized healthcare rebates is ~110€ for a month’s dose of Ozempic, which is in line with the other European countries, so presumably all the prices there are before any rebates.